We are live on ! Find out more
KIDS icon

OrthoPediatrics

129 hedge funds and large institutions have $529M invested in OrthoPediatrics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 20

14% more call options, than puts

Call options by funds: $270K | Put options by funds: $237K

10% more funds holding

Funds holding: 117129 (+12)

5% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 39

1% more capital invested

Capital invested by funds: $521M → $529M (+$7.65M)

0.04% less ownership

Funds ownership: 69.69%69.64% (-0.04%)

Holders
129
Holders Change
+12
Holders Change %
+10.26%
% of All Funds
1.88%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
33
Increased
41
Reduced
39
Closed
20
Calls
$270K
Puts
$237K
Net Calls
+$33K
Net Calls Change
+$1.07M

KIDS Hedge Fund Activity: Q4 2023 in Review

129 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q4 2023, worth a combined $529M — up 1.5% from $521M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KIDS positions and 20 closed out — a net gain of 13 holders — while 41 added to existing stakes and 39 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $11.5M. The largest seller was Riverbridge Partners, cutting an estimated $16M.

  • 129 institutional investors held OrthoPediatrics (KIDS) as of Q4 2023, up from 117 in Q3 2023.
  • Funds reported $529M of OrthoPediatrics stock for Q4 2023, up 1.5% quarter-over-quarter.
  • 33 funds opened new OrthoPediatrics positions in Q4 2023 and 20 closed out, a net change of +13 holders.
  • The largest OrthoPediatrics buyer in Q4 2023 was Morgan Stanley, an estimated $11.5M added.
  • The largest OrthoPediatrics seller in Q4 2023 was Riverbridge Partners, an estimated $16M sold.

Based on aggregated 13F filings for Q4 2023.